These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11332999)

  • 1. Substance use management: a harm reduction-principled approach to assisting the relief of drug-related problems.
    Bigg D
    J Psychoactive Drugs; 2001; 33(1):33-8. PubMed ID: 11332999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating harm reduction therapy and traditional substance abuse treatment.
    Marlatt GA; Blume AW; Parks GA
    J Psychoactive Drugs; 2001; 33(1):13-21. PubMed ID: 11332996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for implementation of harm reduction in treatment settings.
    Denning P
    J Psychoactive Drugs; 2001; 33(1):23-6. PubMed ID: 11332997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction therapy with families and friends of people with drug problems.
    Denning P
    J Clin Psychol; 2010 Feb; 66(2):164-74. PubMed ID: 20049921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse interventions for parents involved in the child welfare system: evidence and implications.
    Osterling KL; Austin MJ
    J Evid Based Soc Work; 2008; 5(1-2):157-89. PubMed ID: 19064448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction psychotherapy: an innovative alternative to classical addictions theory.
    Denning P
    Am Clin Lab; 2002 May; 21(4):16-8. PubMed ID: 12087633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of harm reduction when drug users say they want abstinence?
    Neale J; Nettleton S; Pickering L
    Int J Drug Policy; 2011 May; 22(3):189-93. PubMed ID: 21055914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging the gap in San Francisco: the process of integrating harm reduction and traditional substance abuse services.
    Gleghorn A; Rosenbaum M; Garcia BA
    J Psychoactive Drugs; 2001; 33(1):1-7. PubMed ID: 11332995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Addiction and brief-systemic therapy: working with compulsion].
    Cottencin O; Doutrelugne Y; Goudemand M; Consoli SM
    Encephale; 2009 Jun; 35(3):214-9. PubMed ID: 19540406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in responding to drug misuse problems.
    Tongue E; Turner D
    Bull Narc; 1988; 40(1):3-19. PubMed ID: 3064842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of dually diagnosed clients.
    Little J
    J Psychoactive Drugs; 2001; 33(1):27-31. PubMed ID: 11332998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL; McCann MJ; Marinelli-Casey P; Weiner A; Minsky S; Brethen P; Rawson R
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the integration of treatment systems for substance abusers: report on the second International Symposium on Substance Abuse Treatment and Special Target Groups.
    Broekaert E; Vanderplasschen W
    J Psychoactive Drugs; 2003; 35(2):237-45. PubMed ID: 12924746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severely and persistently mentally ill substance abusers: clinical and policy issues.
    Zweben JE
    J Psychoactive Drugs; 2000; 32(4):383-9. PubMed ID: 11210200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can encouraging substance abuse patients to participate in self-help groups reduce demand for health care? A quasi-experimental study.
    Humphreys K; Moos R
    Alcohol Clin Exp Res; 2001 May; 25(5):711-6. PubMed ID: 11371720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the neurobiology, assessment, and treatment of substances of abuse and dependence: a guide for the critical care nurse.
    Genung V
    Crit Care Nurs Clin North Am; 2012 Mar; 24(1):117-30. PubMed ID: 22405717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.